Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2010
09/08/2010CN101822802A Externally applied Chinese patent medicine for treating obesity and preparation method thereof
09/08/2010CN101822794A Medicine for treating diabetes and preparation method thereof
09/08/2010CN101822793A Beef heart grass tea for treating diabetes and preparation method thereof
09/08/2010CN101822785A Method for extracting corn sterol
09/08/2010CN101822754A Double-frequency ultrasound-assisted extraction method for grape seed extract and application of grape seed extract as lipase inhibitor
09/08/2010CN101822751A Tea essence soft capsules and preparation method thereof
09/08/2010CN101822749A Medicinal preparation for curing hypertension and hyperlipaemia and preparation method thereof
09/08/2010CN101822733A Medicinal composition with function of reducing blood fat and preparation method thereof
09/08/2010CN101822698A Method for preparing black fungus and pantotrichum hypoglycemic composition
09/08/2010CN101822691A Eggshell calcium
09/08/2010CN101822690A Composition of dextran 40 and sodium lactate Ringer' solution and preparation method
09/08/2010CN101822683A Medical care application of L-arabinose composition
09/08/2010CN101822672A Compound with metformin and repaglinide, preparation method thereof and application thereof
09/08/2010CN101822667A Medicine composition containing imidazole-5-carboxylic acid derivatives
09/08/2010CN101822662A Application of 9,10-dioxystearic acid (DHSA) in preparing medicaments for preventing and treating diabetes
09/08/2010CN101822661A Immune function-improving agent
09/08/2010CN101822660A Rhein compound or application of salt thereof in preparing drugs preventing and curing hypofunction of islet beta cell
09/08/2010CN101822658A Cysteamines for treating complications of hypercholesterolemia and diabetes
09/08/2010CN101822651A Chewable capsule and preparation method thereof
09/08/2010CN101822648A Preparation method and application of nano dobesilate calcium capsule or tablet
09/08/2010CN101822647A Tartaric acid rogridone dispersing tablet and preparation method thereof
09/08/2010CN101822638A Nano-emulsion of stilbene compound and preparation method thereof
09/08/2010CN101822622A Preparation method and application of nano-citrulline gel
09/08/2010CN101401785B Amino acid injection and preparation method thereof
09/08/2010CN101264255B Chinese medicinal composition for treating diabetes and preparation thereof
09/08/2010CN101214049B Health food with auxiliary blood fat reducing function
09/08/2010CN101167953B Traditional Chinese-medicinal capsule for comprehensive treating diabetes and its producing process
09/08/2010CN101129388B Pharmaceutical composition of compound fat-soluble vitamin and method of preparing the same
09/08/2010CN101077360B Medicinal composition for treating sugar diabetes skin ulcer and preparation method thereof
09/08/2010CN101057674B Composition for preventing and curing diabetes
09/08/2010CN101044123B Pyrimidine derivative fused with nonaromatic ring
09/08/2010CN101037420B New crystal type of netoglitazone and preparation method thereof
09/08/2010CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation
09/08/2010CN101002843B Medicine composition used for treating cardiovascular and cerebrovascular diseases
09/07/2010US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
09/07/2010US7790773 a cyclopentene sugar amine derivative useful as beta -galactosidase stabilizing agent
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790725 Thiazolidine derivatives and medicinal use thereof
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010US7790711 Inhibitors of 11β-Hydroxysteroid Dehydrogenase
09/07/2010US7790703 New phosphonate ester derivatives of purine or pyrimidine antivirals; side effect reduction, less toxic, bioavailability
09/07/2010US7790700 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
09/07/2010US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT
09/07/2010US7790408 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
09/07/2010US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010CA2590533C 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
09/07/2010CA2454785C 4-oxoimidazolidine-2-spiropiperidine derivatives
09/07/2010CA2368814C Use of glucosylceramide synthesis inhibitors in therapy
09/07/2010CA2226177C Analogs of parathyroid hormone
09/06/2010CA2657291A1 Symbiotic maple product compositions and methods
09/02/2010WO2010099341A1 Compositions and methods for inhibiting expression of mig-12 gene
09/02/2010WO2010098625A2 Pharmaceutical preparation
09/02/2010WO2010098484A1 Process for producing carotenoid
09/02/2010WO2010098482A1 Stable capsule preparation and method for producing same
09/02/2010WO2010098417A1 Magnesium oxide fine granules
09/02/2010WO2010098298A1 Pharmaceutical composition comprising combination of compound having nutrient digestion/absorption inhibitory activity and cyclohexanecarboxamide derivative
09/02/2010WO2010098286A1 Pharmaceutical preparation containing mineralcorticoid receptor antagonist
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098131A1 Agent for prevention or amelioration of obesity
09/02/2010WO2010098125A1 Retinoid x receptor partial agonist compound
09/02/2010WO2010097468A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010096875A1 A drug identification protocol for type 2 diabetes based on gene expression signatures
09/02/2010WO2010096854A1 Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors
09/02/2010WO2010053861A3 Biologically active amides
09/02/2010WO2010044885A3 Soluble mtor complexes and modulators thereof
09/02/2010US20100222657 Method for glucose monitoring using fluorescence quenching
09/02/2010US20100222436 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
09/02/2010US20100222435 Modified-release formulations of a bupropion salt
09/02/2010US20100222431 Novel phenylurea inhibitors of the soat-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
09/02/2010US20100222412 Modulation of glucocorticoid receptor expression
09/02/2010US20100222408 Methods and Compositions for Treatment of Cystic Fibrosis
09/02/2010US20100222398 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
09/02/2010US20100222394 Method for producing pyrazol-3-yl-benzamide derivative
09/02/2010US20100222393 Muscarinic receptor antagonists
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222373 Crystalline Form of Bis [(E)-7-[4-(4-fluoro-phenyl)-6-isopropyl-2-[methyl(methyl-sulfonyl)amino] pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt
09/02/2010US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222350 Phenyl, pyridine, quinoline, isoquinoline, naphthyridine and pyrazine derivatives
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES
09/02/2010US20100222330 New Compounds
09/02/2010US20100222324 Substituted Indole Compounds
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/02/2010US20100222315 Patient populations and treatment methods
09/02/2010US20100222311 Solid formulations of crystalline compounds
09/02/2010US20100222305 Complexes of phosphate derivatives
09/02/2010US20100222301 Topical drug for treatment and/or prevention of diabetic neuropathy, microangiopathy and diabetic and non diabetic ulcers and wound infection
09/02/2010US20100222300 A2B Adenosine Receptor Antagonists
09/02/2010US20100222285 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
09/02/2010US20100222278 Use of leptin for the prevention of excess body weight and composition containing leptin
09/02/2010US20100222277 Regulation of Food Preference Using GLP-1 Agonists
09/02/2010US20100222269 Improved derivatives of amylin
09/02/2010US20100222262 Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
09/02/2010US20100222259 Compositions for enhancing the production of PPAR and/or PPAR-associated factors
09/02/2010US20100222251 Mixture comprising an amylin peptide and a protracted insulin
09/02/2010US20100221359 Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin
1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 1298